Cite

HARVARD Citation

    Borchmann, S. et al. (2022). Tripartite antigen-agnostic combination immunotherapy cures established poorly immunogenic tumors. Journal for immunotherapy of cancer. 10 (10), p. . [Online]. 
  
Back to record